Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population

Journal of Urology

Volumn 157, Issue 2, 1997, Pages 638-640

  Palmer, Lane S ^a   Zebold, Kerry ^a   Firlit, Casimir F ^a   Kaplan, William E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

administration; bladder; complications; intravesical; meningomyelocele

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYOSCYAMINE; IMIPRAMINE; OXYBUTYNIN; PROPANTHELINE BROMIDE; SPASMOLYTIC AGENT;

AGORAPHOBIA; ARTICLE; BLADDER CATHETERIZATION; CHILD; CLINICAL ARTICLE; HEADACHE; HUMAN; HYPERACTIVITY; INJECTION PAIN; INSOMNIA; INTRAVESICAL DRUG ADMINISTRATION; MENINGOMYELOCELE; MYELODYSPLASIA; NAUSEA; NEUROGENIC BLADDER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; TABLET; VERTIGO; XEROSTOMIA;

EID: 0031012539     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65238-8     Document Type: Article

References (13)

1. Madersbacher, H. and Jilg, G.: Control of detrusor hyperreflexia by the intravesical instillation of oxybutynin hydrochloride. Paraplegia, 29: 84, 1991.
2. Mitchell, M. E. and Piser, J. A.: Intestinocystoplasty and total bladder replacement in children and young adults: followup in 129 cases. J. Urol., 138: 579, 1987.
3. Cartwright, P. C. and Snow, B. W.: Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J. Urol., 142: 1050, 1989.
4. Kaplan, W. E., Richards, T. W. and Richards, I.: Intravesical transurethral bladder stimulation to increase bladder capacity. J. Urol., part 2, 142: 600, 1989.
5. Greenfield, S. P. and Fera, M.: The use of intravesical oxybutynin chloride in children with neurogenic bladder. J. Urol., 146: 532, 1991.
6. Connor, J. P., Betrus, G., Fleming, P., Perlmutter, A. D. and Reitelman, C.: Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J. Urol., 151: 1045, 1994.
7. Kasabian, N. G., Vlachiotis, J. D., Lais, A., Klumpp, B., Kelly, M. D., Siroky, M. B. and Bauer, S. B.: The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. J. Urol., 151: 944, 1994.
8. Massad, C. A., Kogan, B. A. and Trigo-Rocha, F. E.: The pharmacokinetics of intravesical and oral oxybutynin chloride. J. Urol., part 2, 148: 595, 1992.
9. Lapides, J., Diokno, A. C., Silber, S. J. and Lowe, B. S.: Clean, intermittent self-catheterization in the treatment of urinary tract disease. J. Urol., 107: 458, 1972.
10. McGuire, E. J., Woodside, J. R., Borden, T. A. and Weiss, R. M.: Prognostic value of urodynamic testing in myelodysplastic patients. J. Urol., 126: 205, 1981.
11. Physician's Desk Reference. Montvale, New Jersey: Medical Economics Data Production Co., p. 1407, 1995.
12. Brendler, C. B., Radebaugh, L. C. and Mohler, J. L.: Topical oxybutynin chloride for relaxation of dysfunctional bladders. J. Urol., 141: 1350, 1989.
13. Weese, D. L., Roskamp, D. A., Leach, G. E. and Zimmern, P. E.: Intravesical oxybutynin chloride: experience with 42 patients. Urology, 41: 527, 1993.